On the recordApril 4, 2022
And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost.
Source
congress.govEditor's note · Context
Criticizing the misuse of safety programs to hinder generic drug development.
Share & report
More from Maggie Hassan
Sep 18, 2024
Mr. President, I ask unanimous consent that the Senate proceed to legislative session and be in a period of morning business, with Senators permitted to speak therein for up to 10 minutes each. ____________________
Sep 17, 2024
Our nonpartisan civil service is essential for our government to operate effectively and protect U.S. national security interests.
Sep 24, 2024
It is outrageous that these companies... are putting profiting off of their deals with the Saudis over protecting the national security interests of the United States.
Other voices in this conversation
